Fatigue in patients with cancer receiving interferon alpha

G. E. Dean, L. Spears, Betty Ferrell, W. D Y Quan, S. Groshon, M. S. Mitchell

Research output: Contribution to journalArticle

Abstract

Fatigue is the most frequently reported symptom of patients with cancer. The purpose of this study was to describe the experience of fatigue over time in patients with cancer receiving treatment with interferon alpha. Piper's Integrated Fatigue Model guided this study. A descriptive repeated-measures design was used. A convenience sample of 30 patients with malignant melanoma was drawn from a comprehensive cancer center in Southern California. Two instruments were used in data collection, the Symptom Distress Scale and the Piper Fatigue Scale. Study findings revealed descriptive data on patients' perceptions of the causes and remedies for fatigue while receiving active treatment for cancer. The pattern of fatigue was consistent over the five points of time during treatment, with the most extreme fatigue scores in the affective domain, followed by the sensory, temporal, total fatigue, and fatigue severity scores. The patterns and dimensions of fatigue provide implications for care of patients receiving interferon alpha, and for further investigation in the area of fatigue as a critical aspects of quality of life.

Original languageEnglish (US)
Pages (from-to)164-172
Number of pages9
JournalCancer Practice
Volume3
Issue number3
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Interferon-alpha
Fatigue
Neoplasms
Piper
Melanoma
Patient Care
Therapeutics
Quality of Life

Keywords

  • fatigue
  • interferon alpha
  • quality of life
  • subjective fatigue
  • symptom distress

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

Dean, G. E., Spears, L., Ferrell, B., Quan, W. D. Y., Groshon, S., & Mitchell, M. S. (1995). Fatigue in patients with cancer receiving interferon alpha. Cancer Practice, 3(3), 164-172.

Fatigue in patients with cancer receiving interferon alpha. / Dean, G. E.; Spears, L.; Ferrell, Betty; Quan, W. D Y; Groshon, S.; Mitchell, M. S.

In: Cancer Practice, Vol. 3, No. 3, 01.01.1995, p. 164-172.

Research output: Contribution to journalArticle

Dean, GE, Spears, L, Ferrell, B, Quan, WDY, Groshon, S & Mitchell, MS 1995, 'Fatigue in patients with cancer receiving interferon alpha', Cancer Practice, vol. 3, no. 3, pp. 164-172.
Dean GE, Spears L, Ferrell B, Quan WDY, Groshon S, Mitchell MS. Fatigue in patients with cancer receiving interferon alpha. Cancer Practice. 1995 Jan 1;3(3):164-172.
Dean, G. E. ; Spears, L. ; Ferrell, Betty ; Quan, W. D Y ; Groshon, S. ; Mitchell, M. S. / Fatigue in patients with cancer receiving interferon alpha. In: Cancer Practice. 1995 ; Vol. 3, No. 3. pp. 164-172.
@article{242671ec96244f549d1956abd5a74e6b,
title = "Fatigue in patients with cancer receiving interferon alpha",
abstract = "Fatigue is the most frequently reported symptom of patients with cancer. The purpose of this study was to describe the experience of fatigue over time in patients with cancer receiving treatment with interferon alpha. Piper's Integrated Fatigue Model guided this study. A descriptive repeated-measures design was used. A convenience sample of 30 patients with malignant melanoma was drawn from a comprehensive cancer center in Southern California. Two instruments were used in data collection, the Symptom Distress Scale and the Piper Fatigue Scale. Study findings revealed descriptive data on patients' perceptions of the causes and remedies for fatigue while receiving active treatment for cancer. The pattern of fatigue was consistent over the five points of time during treatment, with the most extreme fatigue scores in the affective domain, followed by the sensory, temporal, total fatigue, and fatigue severity scores. The patterns and dimensions of fatigue provide implications for care of patients receiving interferon alpha, and for further investigation in the area of fatigue as a critical aspects of quality of life.",
keywords = "fatigue, interferon alpha, quality of life, subjective fatigue, symptom distress",
author = "Dean, {G. E.} and L. Spears and Betty Ferrell and Quan, {W. D Y} and S. Groshon and Mitchell, {M. S.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "164--172",
journal = "Cancer Practice",
issn = "1065-4704",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Fatigue in patients with cancer receiving interferon alpha

AU - Dean, G. E.

AU - Spears, L.

AU - Ferrell, Betty

AU - Quan, W. D Y

AU - Groshon, S.

AU - Mitchell, M. S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Fatigue is the most frequently reported symptom of patients with cancer. The purpose of this study was to describe the experience of fatigue over time in patients with cancer receiving treatment with interferon alpha. Piper's Integrated Fatigue Model guided this study. A descriptive repeated-measures design was used. A convenience sample of 30 patients with malignant melanoma was drawn from a comprehensive cancer center in Southern California. Two instruments were used in data collection, the Symptom Distress Scale and the Piper Fatigue Scale. Study findings revealed descriptive data on patients' perceptions of the causes and remedies for fatigue while receiving active treatment for cancer. The pattern of fatigue was consistent over the five points of time during treatment, with the most extreme fatigue scores in the affective domain, followed by the sensory, temporal, total fatigue, and fatigue severity scores. The patterns and dimensions of fatigue provide implications for care of patients receiving interferon alpha, and for further investigation in the area of fatigue as a critical aspects of quality of life.

AB - Fatigue is the most frequently reported symptom of patients with cancer. The purpose of this study was to describe the experience of fatigue over time in patients with cancer receiving treatment with interferon alpha. Piper's Integrated Fatigue Model guided this study. A descriptive repeated-measures design was used. A convenience sample of 30 patients with malignant melanoma was drawn from a comprehensive cancer center in Southern California. Two instruments were used in data collection, the Symptom Distress Scale and the Piper Fatigue Scale. Study findings revealed descriptive data on patients' perceptions of the causes and remedies for fatigue while receiving active treatment for cancer. The pattern of fatigue was consistent over the five points of time during treatment, with the most extreme fatigue scores in the affective domain, followed by the sensory, temporal, total fatigue, and fatigue severity scores. The patterns and dimensions of fatigue provide implications for care of patients receiving interferon alpha, and for further investigation in the area of fatigue as a critical aspects of quality of life.

KW - fatigue

KW - interferon alpha

KW - quality of life

KW - subjective fatigue

KW - symptom distress

UR - http://www.scopus.com/inward/record.url?scp=0029005622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029005622&partnerID=8YFLogxK

M3 - Article

C2 - 7599673

AN - SCOPUS:0029005622

VL - 3

SP - 164

EP - 172

JO - Cancer Practice

JF - Cancer Practice

SN - 1065-4704

IS - 3

ER -